Cooperative STAT/NF-κB signaling regulates lymphoma metabolic reprogramming and aberrant GOT2 expression.
Maren FeistPhilipp SchwarzfischerPaul HeinrichXueni SunJudith KemperFrederike von BoninPaula Perez-RubioFranziska TaruttisThorsten RehbergKatja DettmerWolfram GronwaldJörg ReindersJulia C EngelmannJan DudekWolfram KlapperLorenz TrümperRainer SpangPeter J OefnerDieter KubePublished in: Nature communications (2018)
Knowledge of stromal factors that have a role in the transcriptional regulation of metabolic pathways aside from c-Myc is fundamental to improvements in lymphoma therapy. Using a MYC-inducible human B-cell line, we observed the cooperative activation of STAT3 and NF-κB by IL10 and CpG stimulation. We show that IL10 + CpG-mediated cell proliferation of MYClow cells depends on glutaminolysis. By 13C- and 15N-tracing of glutamine metabolism and metabolite rescue experiments, we demonstrate that GOT2 provides aspartate and nucleotides to cells with activated or aberrant Jak/STAT and NF-κB signaling. A model of GOT2 transcriptional regulation is proposed, in which the cooperative phosphorylation of STAT3 and direct joint binding of STAT3 and p65/NF-κB to the proximal GOT2 promoter are important. Furthermore, high aberrant GOT2 expression is prognostic in diffuse large B-cell lymphoma underscoring the current findings and importance of stromal factors in lymphoma biology.
Keyphrases
- diffuse large b cell lymphoma
- cell proliferation
- pi k akt
- signaling pathway
- cell cycle arrest
- induced apoptosis
- lps induced
- epstein barr virus
- dna methylation
- oxidative stress
- nuclear factor
- poor prognosis
- endothelial cells
- bone marrow
- healthcare
- binding protein
- endoplasmic reticulum stress
- gene expression
- toll like receptor
- immune response
- pluripotent stem cells